Clinical features of febrile seizures in children with COVID-19: an observational study from a tertiary care hospital in China

作者：Cuiyun Fang, Yuan Zhou, Wei Fan, Chunsheng Zhang, Yi Yang · 发表于：Frontiers in Pediatrics · 年份：2023 · DOI：10.3389/fped.2023.1290806 · 被引用次数：4 · 研究领域：Long-Term Effects of COVID-19、Epilepsy research and treatment、Infectious Encephalopathies and Encephalitis

Background Febrile seizures are a common neurologic manifestation in children with coronavirus disease 2019 (COVID-19). Compared to seasonal respiratory viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a pronounced neurological impact, with the result that febrile seizures with COVID-19 may exhibit unique clinical features. Materials and methods We conducted a retrospective study in a tertiary care hospital in China. We collected medical record information on febrile seizures with COVID-19, including demographic characteristics, clinical features, laboratory tests, and disease burden. Subsequently, the data were then analyzed descriptively. Results A total of 103 children diagnosed with febrile seizures and positive COVID-19 PCR results were included in our study. Among them, 81 (78.6%) were males and 22 (21.4%) were females. The age of onset of febrile seizures ranged from 14 to 57 months, with a mean age of 34.9 ± 6.24 months. Complex febrile seizures were observed in 34 (33%) cases. Antiseizure medications were administered to 24 (23.3%) patients. Laboratory tests showed a white blood cell count of (27.05 ± 8.20) × 10 3 /µl, a neutrophil count of (20.09 ± 5.66) × 10 3 /µl and a lymphocyte count of (6.44 ± 1.86) × 10 3 /µl. A creatine kinase level was significantly elevated, with a mean value of (412.00 ± 158.96) U/L. The mean length of stay was 4.36 days. Twelve patients (11.7%) required intensive care services, but there were no deaths or patients...